Simplified phosphorescent organic light-emitting diodes (OLEDs) using only two kinds of hosts and comprising either a neat MoO(x) hole-injecting layer (HIL) or a MoO(x)-doped 4,4'-bis(carbazol-9-yl)biphenyl (CBP) HIL were studied. The devices having the MoO(x)-doped CBP HIL are superior to the device having the neat MoO(x) HIL in terms of power efficiency and operational lifetime. Impedance spectroscopy studies revealed that both the reduced hole-injecting barrier height at the anode/doped HIL interface and the reduced bulk resistivity in the doped CBP HIL contribute to the improvement in electroluminescence characteristics. When increasing the MoO(x) volume percentage from 5 to 10% and then to 20%, the hole-injecting barrier height is decreased from 0.63 eV to 0.36 eV and then to 0.18 eV. The power efficiency of the device with a 20 vol % of MoO(x)-doped CBP HIL is more than two times that of the device with a neat MoO(x) HIL measured at a driven current of 5 mA/cm(2). Moreover, the lifetime of the device with a 20 vol % of MoO(x)-doped CBP HIL is more than three times that of the device with a neat MoO(x) HIL estimated at an initial luminance of 1000 cd/m(2). The MoO(x)-doped HIL further ensures the feasibility of the simplified phosphorescent OLEDs for potential applications.
No takes yet. Share an insight, caveat, or question.
Cai et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: